Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Talis Biomedical Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −5 vs. Q4 2022
- Shares held
- 11.8M
- −821.0K (−6.5%) vs. Q4 2022
- Total value
- $5.76M
- +$157.2K (+2.8%) vs. Q4 2022
- New holders
- 1
- 4 more added
- Sold out
- 6
- 5 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLIS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $26 |
| Q3 2024 | 2 | $460.4K |
| Q2 2024 | 18 | $6.84M |
| Q1 2024 | 18 | $6.93M |
| Q4 2023 | 18 | $5.93M |
| Q3 2023 | 19 | $4.27M |
| Q2 2023 | 22 | $5.27M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 27 | $5.60M |
| Q3 2022 | 29 | $8.59M |
| Q2 2022 | 35 | $12.1M |
| Q1 2022 | 45 | $23.6M |
| Q4 2021 | 47 | $70.2M |
| Q3 2021 | 38 | $119.2M |
| Q2 2021 | 43 | $184.0M |
| Q1 2021 | 45 | $269.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Talis Biomedical Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 123 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 527 | $0 | 0.00% | +527 | New |
| New England Capital Financial Advisors LLC | 10 | $5 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 26 | $13 | 0.00% | −6,717−99.6% | Reduced |
| Wells Fargo & Company | 167 | $82 | 0.00% | +3+1.8% | Added |
| Larson Financial Group LLC | 200 | $98 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,564 | $766 | 0.00% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 27,860 | $13.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 42,500 | $21.0K | 0.00% | +7,600+21.8% | Added |
| State Street Corp | 49,536 | $24.3K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 60,120 | $29.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 60,857 | $29.8K | 0.00% | +1,262+2.1% | Added |
| Mercer Global Advisors Inc | 79,880 | $39.0K | 0.00% | −1,400−1.7% | Reduced |
| BlackRock Inc. | 82,463 | $40.4K | 0.00% | −14,496−15.0% | Reduced |
| Geode Capital Management, LLC | 144,416 | $70.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 163,663 | $80.0K | 0.00% | +52,627+47.4% | Added |
| Prelude Capital Management, LLC | 223,934 | $109.7K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 471,426 | $231.0K | 0.00% | −22,735−4.6% | Reduced |
| ArrowMark Colorado Holdings LLC | 478,862 | $234.6K | 0.00% | −680,154−58.7% | Reduced |
| Greenlight Capital Inc | 2,235,783 | $1.10M | 0.06% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 7,624,835 | $3.74M | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −95,060−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −32,075−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −19,409−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,760−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −164−100.0% | Sold out |